nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—head and neck cancer—pharynx cancer	0.575	1	CtDrD
Docetaxel—EGFR—pharynx cancer	0.378	1	CbGaD
Docetaxel—GHRHR—brainstem—pharynx cancer	0.00208	0.0589	CbGeAlD
Docetaxel—GHRHR—head—pharynx cancer	0.00115	0.0326	CbGeAlD
Docetaxel—BCL2—mouth—pharynx cancer	0.00114	0.0321	CbGeAlD
Docetaxel—BCL2—neck—pharynx cancer	0.000971	0.0275	CbGeAlD
Docetaxel—MAP2—neck—pharynx cancer	0.000841	0.0238	CbGeAlD
Docetaxel—MAP4—brainstem—pharynx cancer	0.000817	0.0231	CbGeAlD
Docetaxel—NR1I2—head—pharynx cancer	0.00069	0.0195	CbGeAlD
Docetaxel—KIF11—lymph node—pharynx cancer	0.000686	0.0194	CbGeAlD
Docetaxel—MAP2—parotid gland—pharynx cancer	0.000685	0.0194	CbGeAlD
Docetaxel—TUBB8—head—pharynx cancer	0.000661	0.0187	CbGeAlD
Docetaxel—BCL2—epithelium—pharynx cancer	0.000661	0.0187	CbGeAlD
Docetaxel—MAP2—saliva-secreting gland—pharynx cancer	0.000656	0.0186	CbGeAlD
Docetaxel—MAPT—spinal cord—pharynx cancer	0.000646	0.0183	CbGeAlD
Docetaxel—MAP2—brainstem—pharynx cancer	0.000643	0.0182	CbGeAlD
Docetaxel—TUBB3—lymphoid tissue—pharynx cancer	0.00056	0.0158	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—pharynx cancer	0.00056	0.0158	CbGeAlD
Docetaxel—MAPT—Signaling mediated by p38-gamma and p38-delta—CCND1—pharynx cancer	0.000557	0.0475	CbGpPWpGaD
Docetaxel—TUBB2B—parotid gland—pharynx cancer	0.000512	0.0145	CbGeAlD
Docetaxel—BCL2—lymphoid tissue—pharynx cancer	0.000509	0.0144	CbGeAlD
Docetaxel—MAP4—spinal cord—pharynx cancer	0.000508	0.0144	CbGeAlD
Docetaxel—MAP2—trachea—pharynx cancer	0.000506	0.0143	CbGeAlD
Docetaxel—TUBB4A—brainstem—pharynx cancer	0.000497	0.014	CbGeAlD
Docetaxel—TUBB2B—saliva-secreting gland—pharynx cancer	0.00049	0.0139	CbGeAlD
Docetaxel—TUBB—parotid gland—pharynx cancer	0.000484	0.0137	CbGeAlD
Docetaxel—TUBB2A—parotid gland—pharynx cancer	0.000482	0.0136	CbGeAlD
Docetaxel—TUBB6—parotid gland—pharynx cancer	0.000475	0.0134	CbGeAlD
Docetaxel—TUBB—saliva-secreting gland—pharynx cancer	0.000464	0.0131	CbGeAlD
Docetaxel—TUBB2A—saliva-secreting gland—pharynx cancer	0.000461	0.013	CbGeAlD
Docetaxel—TUBB6—saliva-secreting gland—pharynx cancer	0.000455	0.0129	CbGeAlD
Docetaxel—TUBB3—head—pharynx cancer	0.000451	0.0128	CbGeAlD
Docetaxel—MAP4—head—pharynx cancer	0.000451	0.0128	CbGeAlD
Docetaxel—TUBB1—head—pharynx cancer	0.000441	0.0125	CbGeAlD
Docetaxel—ABCC10—parotid gland—pharynx cancer	0.000416	0.0118	CbGeAlD
Docetaxel—TUBB4B—parotid gland—pharynx cancer	0.000413	0.0117	CbGeAlD
Docetaxel—BCL2—head—pharynx cancer	0.00041	0.0116	CbGeAlD
Docetaxel—MAPT—lymph node—pharynx cancer	0.000402	0.0114	CbGeAlD
Docetaxel—MAP2—spinal cord—pharynx cancer	0.0004	0.0113	CbGeAlD
Docetaxel—ABCC10—saliva-secreting gland—pharynx cancer	0.000398	0.0113	CbGeAlD
Docetaxel—TUBB6—epithelium—pharynx cancer	0.000397	0.0112	CbGeAlD
Docetaxel—TUBB4B—saliva-secreting gland—pharynx cancer	0.000396	0.0112	CbGeAlD
Docetaxel—TUBB2B—trachea—pharynx cancer	0.000378	0.0107	CbGeAlD
Docetaxel—TUBB—trachea—pharynx cancer	0.000358	0.0101	CbGeAlD
Docetaxel—TUBB2A—trachea—pharynx cancer	0.000356	0.0101	CbGeAlD
Docetaxel—MAP2—head—pharynx cancer	0.000355	0.01	CbGeAlD
Docetaxel—TUBB6—trachea—pharynx cancer	0.000351	0.00993	CbGeAlD
Docetaxel—TUBB4A—lymphoid tissue—pharynx cancer	0.000341	0.00964	CbGeAlD
Docetaxel—TUBB8—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.000328	0.028	CbGpPWpGaD
Docetaxel—MAP4—lymph node—pharynx cancer	0.000316	0.00893	CbGeAlD
Docetaxel—TUBB4A—spinal cord—pharynx cancer	0.000309	0.00874	CbGeAlD
Docetaxel—ABCC10—trachea—pharynx cancer	0.000307	0.00869	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—pharynx cancer	0.000306	0.00865	CbGeAlD
Docetaxel—TUBB4B—trachea—pharynx cancer	0.000305	0.00863	CbGeAlD
Docetaxel—TUBB2B—spinal cord—pharynx cancer	0.000299	0.00844	CbGeAlD
Docetaxel—ABCC1—parotid gland—pharynx cancer	0.000294	0.00832	CbGeAlD
Docetaxel—BCL2—lymph node—pharynx cancer	0.000287	0.00812	CbGeAlD
Docetaxel—EGFR—lymph node—pharynx cancer	0.000284	0.00802	CbGeAlD
Docetaxel—TUBB—spinal cord—pharynx cancer	0.000283	0.00799	CbGeAlD
Docetaxel—TUBB2A—spinal cord—pharynx cancer	0.000281	0.00795	CbGeAlD
Docetaxel—TUBB6—spinal cord—pharynx cancer	0.000277	0.00784	CbGeAlD
Docetaxel—MAPT—Apoptotic cleavage of cellular proteins—CDH1—pharynx cancer	0.000277	0.0237	CbGpPWpGaD
Docetaxel—TUBB4A—head—pharynx cancer	0.000275	0.00776	CbGeAlD
Docetaxel—ABCC10—lymphoid tissue—pharynx cancer	0.000268	0.00757	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—pharynx cancer	0.000266	0.00752	CbGeAlD
Docetaxel—TUBB2B—head—pharynx cancer	0.000265	0.0075	CbGeAlD
Docetaxel—TUBB2A—head—pharynx cancer	0.00025	0.00706	CbGeAlD
Docetaxel—MAP2—lymph node—pharynx cancer	0.000249	0.00703	CbGeAlD
Docetaxel—TUBB6—head—pharynx cancer	0.000246	0.00697	CbGeAlD
Docetaxel—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.000245	0.0209	CbGpPWpGaD
Docetaxel—ABCG2—parotid gland—pharynx cancer	0.000244	0.00689	CbGeAlD
Docetaxel—ABCC10—spinal cord—pharynx cancer	0.000243	0.00686	CbGeAlD
Docetaxel—TUBB4B—spinal cord—pharynx cancer	0.000241	0.00681	CbGeAlD
Docetaxel—ABCG2—saliva-secreting gland—pharynx cancer	0.000233	0.0066	CbGeAlD
Docetaxel—CYP1B1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000227	0.0194	CbGpPWpGaD
Docetaxel—MAP2—LKB1 signaling events—TP53—pharynx cancer	0.00022	0.0188	CbGpPWpGaD
Docetaxel—ABCC1—trachea—pharynx cancer	0.000217	0.00615	CbGeAlD
Docetaxel—MAPT—Apoptotic execution phase—CDH1—pharynx cancer	0.000216	0.0184	CbGpPWpGaD
Docetaxel—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.000214	0.0183	CbGpPWpGaD
Docetaxel—TUBB4B—head—pharynx cancer	0.000214	0.00606	CbGeAlD
Docetaxel—CYP1B1—lymphoid tissue—pharynx cancer	0.000211	0.00595	CbGeAlD
Docetaxel—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000205	0.0175	CbGpPWpGaD
Docetaxel—CYP1B1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.000199	0.017	CbGpPWpGaD
Docetaxel—TUBB4A—lymph node—pharynx cancer	0.000192	0.00544	CbGeAlD
Docetaxel—TUBB2B—lymph node—pharynx cancer	0.000186	0.00525	CbGeAlD
Docetaxel—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00018	0.0153	CbGpPWpGaD
Docetaxel—TUBB—lymph node—pharynx cancer	0.000176	0.00497	CbGeAlD
Docetaxel—TUBB2A—lymph node—pharynx cancer	0.000175	0.00495	CbGeAlD
Docetaxel—TUBB6—lymph node—pharynx cancer	0.000173	0.00488	CbGeAlD
Docetaxel—CYP1B1—head—pharynx cancer	0.00017	0.0048	CbGeAlD
Docetaxel—TUBB6—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.000166	0.0141	CbGpPWpGaD
Docetaxel—TUBB2B—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.000166	0.0141	CbGpPWpGaD
Docetaxel—TUBB—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.000164	0.014	CbGpPWpGaD
Docetaxel—EGFR—E-cadherin signaling in keratinocytes—CDH1—pharynx cancer	0.000162	0.0138	CbGpPWpGaD
Docetaxel—MAPT—Copper homeostasis—CCND1—pharynx cancer	0.000161	0.0137	CbGpPWpGaD
Docetaxel—TUBB3—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00016	0.0137	CbGpPWpGaD
Docetaxel—TUBB2A—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.000155	0.0132	CbGpPWpGaD
Docetaxel—TUBB1—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.000152	0.0129	CbGpPWpGaD
Docetaxel—ABCC10—lymph node—pharynx cancer	0.000151	0.00427	CbGeAlD
Docetaxel—TUBB4B—lymph node—pharynx cancer	0.00015	0.00424	CbGeAlD
Docetaxel—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.000148	0.0127	CbGpPWpGaD
Docetaxel—BCL2—TP53 Network—TP53—pharynx cancer	0.000146	0.0124	CbGpPWpGaD
Docetaxel—ABCC2—NRF2 pathway—ADH7—pharynx cancer	0.000144	0.0123	CbGpPWpGaD
Docetaxel—ABCG2—spinal cord—pharynx cancer	0.000142	0.00402	CbGeAlD
Docetaxel—MAPT—Notch Signaling Pathway—CCND1—pharynx cancer	0.000141	0.0121	CbGpPWpGaD
Docetaxel—TUBB4A—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.000136	0.0116	CbGpPWpGaD
Docetaxel—CYP1B1—Biological oxidations—CNDP2—pharynx cancer	0.000134	0.0114	CbGpPWpGaD
Docetaxel—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00013	0.0111	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD79A—pharynx cancer	0.000128	0.0109	CbGpPWpGaD
Docetaxel—TUBB4B—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.000124	0.0106	CbGpPWpGaD
Docetaxel—MAPT—LKB1 signaling events—TP53—pharynx cancer	0.000123	0.0105	CbGpPWpGaD
Docetaxel—ABCC2—lymph node—pharynx cancer	0.000121	0.00343	CbGeAlD
Docetaxel—CYP1B1—Biological oxidations—ADH7—pharynx cancer	0.000121	0.0103	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—CNDP2—pharynx cancer	0.00012	0.0103	CbGpPWpGaD
Docetaxel—CYP1B1—lymph node—pharynx cancer	0.000119	0.00336	CbGeAlD
Docetaxel—EGFR—Bladder Cancer—CDH1—pharynx cancer	0.000119	0.0101	CbGpPWpGaD
Docetaxel—BCL2—Activation of BH3-only proteins—TP53—pharynx cancer	0.000117	0.00998	CbGpPWpGaD
Docetaxel—KIF11—Factors involved in megakaryocyte development and platelet production—TP53—pharynx cancer	0.000115	0.00986	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—ADH7—pharynx cancer	0.000109	0.0093	CbGpPWpGaD
Docetaxel—ABCC1—lymph node—pharynx cancer	0.000107	0.00302	CbGeAlD
Docetaxel—MAPT—LPA receptor mediated events—EGFR—pharynx cancer	0.000107	0.00912	CbGpPWpGaD
Docetaxel—CYP1B1—Biological oxidations—ADH1B—pharynx cancer	0.000106	0.00904	CbGpPWpGaD
Docetaxel—MAPT—Copper homeostasis—TP53—pharynx cancer	0.000106	0.00904	CbGpPWpGaD
Docetaxel—ABCB1—epithelium—pharynx cancer	0.0001	0.00284	CbGeAlD
Docetaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—pharynx cancer	0.0001	0.00855	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—ADH1B—pharynx cancer	9.55e-05	0.00815	CbGpPWpGaD
Docetaxel—EGFR—Stabilization and expansion of the E-cadherin adherens junction—CDH1—pharynx cancer	9.3e-05	0.00794	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—CDH1—pharynx cancer	9e-05	0.00768	CbGpPWpGaD
Docetaxel—BCL2—ATF-2 transcription factor network—CCND1—pharynx cancer	8.93e-05	0.00763	CbGpPWpGaD
Docetaxel—ABCB1—trachea—pharynx cancer	8.88e-05	0.00251	CbGeAlD
Docetaxel—ABCG2—lymph node—pharynx cancer	8.85e-05	0.0025	CbGeAlD
Docetaxel—EGFR—Bladder Cancer—CCND1—pharynx cancer	8.84e-05	0.00754	CbGpPWpGaD
Docetaxel—EGFR—a6b1 and a6b4 Integrin signaling—CDH1—pharynx cancer	8.8e-05	0.00751	CbGpPWpGaD
Docetaxel—SLC22A7—Fluoropyrimidine Activity—TP53—pharynx cancer	8.75e-05	0.00747	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	8.7e-05	0.00743	CbGpPWpGaD
Docetaxel—BCL2—Validated targets of C-MYC transcriptional repression—CCND1—pharynx cancer	8.47e-05	0.00724	CbGpPWpGaD
Docetaxel—BCL2—Intrinsic Pathway for Apoptosis—TP53—pharynx cancer	8.36e-05	0.00714	CbGpPWpGaD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—pharynx cancer	8.36e-05	0.00714	CbGpPWpGaD
Docetaxel—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—pharynx cancer	8.35e-05	0.00713	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—ADH7—pharynx cancer	7.87e-05	0.00672	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD79A—pharynx cancer	7.74e-05	0.00661	CbGpPWpGaD
Docetaxel—ABCB1—lymphoid tissue—pharynx cancer	7.73e-05	0.00219	CbGeAlD
Docetaxel—MAPT—Alzheimers Disease—TP53—pharynx cancer	7.57e-05	0.00647	CbGpPWpGaD
Docetaxel—BCL2—Integrated Cancer Pathway—TP53—pharynx cancer	7.44e-05	0.00635	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—B4GALT5—pharynx cancer	7.23e-05	0.00618	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—B4GALT5—pharynx cancer	7.23e-05	0.00618	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CDH1—pharynx cancer	7.11e-05	0.00607	CbGpPWpGaD
Docetaxel—ABCB1—spinal cord—pharynx cancer	7.01e-05	0.00198	CbGeAlD
Docetaxel—TUBB3—Metabolism of proteins—B4GALT5—pharynx cancer	6.99e-05	0.00597	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	6.9e-05	0.00589	CbGpPWpGaD
Docetaxel—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	6.89e-05	0.00588	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—B4GALT5—pharynx cancer	6.77e-05	0.00578	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—CCND1—pharynx cancer	6.73e-05	0.00575	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—B4GALT5—pharynx cancer	6.62e-05	0.00565	CbGpPWpGaD
Docetaxel—ABCB1—head—pharynx cancer	6.23e-05	0.00176	CbGeAlD
Docetaxel—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	6.04e-05	0.00516	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—B4GALT5—pharynx cancer	5.94e-05	0.00507	CbGpPWpGaD
Docetaxel—EGFR—Bladder Cancer—TP53—pharynx cancer	5.82e-05	0.00497	CbGpPWpGaD
Docetaxel—EGFR—Gastric Cancer Network 2—TP53—pharynx cancer	5.82e-05	0.00497	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	5.67e-05	0.00485	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—CCND1—pharynx cancer	5.67e-05	0.00484	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	5.65e-05	0.00482	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—CDH1—pharynx cancer	5.53e-05	0.00472	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—CCND1—pharynx cancer	5.47e-05	0.00467	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—B4GALT5—pharynx cancer	5.43e-05	0.00464	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	5.19e-05	0.00443	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	5.19e-05	0.00443	CbGpPWpGaD
Docetaxel—ABCG2—Fluoropyrimidine Activity—TP53—pharynx cancer	5.17e-05	0.00441	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—EGFR—pharynx cancer	4.93e-05	0.00421	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—CD79A—pharynx cancer	4.89e-05	0.00417	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Telomerase—CCND1—pharynx cancer	4.71e-05	0.00402	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	4.45e-05	0.0038	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—pharynx cancer	4.43e-05	0.00379	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—TP53—pharynx cancer	4.42e-05	0.00377	CbGpPWpGaD
Docetaxel—ABCB1—lymph node—pharynx cancer	4.36e-05	0.00123	CbGeAlD
Docetaxel—KIF11—Immune System—CDH1—pharynx cancer	4.31e-05	0.00368	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	4.21e-05	0.0036	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—TP53—pharynx cancer	4.16e-05	0.00355	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—EGFR—pharynx cancer	4.16e-05	0.00355	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TP53—pharynx cancer	4.14e-05	0.00354	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	4.06e-05	0.00346	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	4.05e-05	0.00345	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—TP53—pharynx cancer	4.04e-05	0.00345	CbGpPWpGaD
Docetaxel—EGFR—Androgen receptor signaling pathway—CCND1—pharynx cancer	3.8e-05	0.00324	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	3.74e-05	0.00319	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—TP53—pharynx cancer	3.73e-05	0.00319	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—TP53—pharynx cancer	3.71e-05	0.00317	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—ADH7—pharynx cancer	3.66e-05	0.00312	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—pharynx cancer	3.6e-05	0.00307	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—EGFR—pharynx cancer	3.51e-05	0.003	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—CCND1—pharynx cancer	3.5e-05	0.00299	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	3.49e-05	0.00298	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	3.34e-05	0.00285	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CNDP2—pharynx cancer	3.34e-05	0.00285	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	3.3e-05	0.00282	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	3.21e-05	0.00274	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	3.14e-05	0.00268	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—CCND1—pharynx cancer	3.03e-05	0.00259	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ADH7—pharynx cancer	3.02e-05	0.00258	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—TP53—pharynx cancer	2.95e-05	0.00252	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—TP53—pharynx cancer	2.77e-05	0.00237	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—EGFR—pharynx cancer	2.75e-05	0.00235	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	2.74e-05	0.00234	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—pharynx cancer	2.72e-05	0.00232	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	2.67e-05	0.00228	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ADH1B—pharynx cancer	2.65e-05	0.00226	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—B4GALT5—pharynx cancer	2.53e-05	0.00216	CbGpPWpGaD
Docetaxel—KIF11—Immune System—EGFR—pharynx cancer	2.52e-05	0.00215	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	2.49e-05	0.00213	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CNDP2—pharynx cancer	2.36e-05	0.00202	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—EGFR—pharynx cancer	2.35e-05	0.002	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	2.3e-05	0.00196	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CNDP2—pharynx cancer	2.28e-05	0.00195	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—CCND1—pharynx cancer	2.19e-05	0.00187	CbGpPWpGaD
Docetaxel—ABCC1—Disease—B4GALT5—pharynx cancer	2.14e-05	0.00182	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ADH7—pharynx cancer	2.13e-05	0.00182	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CNDP2—pharynx cancer	2.08e-05	0.00177	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—CCND1—pharynx cancer	2.07e-05	0.00177	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ADH7—pharynx cancer	2.06e-05	0.00176	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	2.06e-05	0.00176	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CNDP2—pharynx cancer	2.06e-05	0.00176	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD79A—pharynx cancer	2.02e-05	0.00173	CbGpPWpGaD
Docetaxel—EGFR—Disease—B4GALT5—pharynx cancer	2.01e-05	0.00172	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—pharynx cancer	2e-05	0.00171	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD79A—pharynx cancer	1.97e-05	0.00168	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—CCND1—pharynx cancer	1.96e-05	0.00167	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ADH7—pharynx cancer	1.88e-05	0.0016	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ADH1B—pharynx cancer	1.87e-05	0.0016	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ADH7—pharynx cancer	1.86e-05	0.00159	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—pharynx cancer	1.81e-05	0.00155	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ADH1B—pharynx cancer	1.81e-05	0.00155	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—B4GALT5—pharynx cancer	1.79e-05	0.00153	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCND1—pharynx cancer	1.77e-05	0.00151	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—pharynx cancer	1.74e-05	0.00149	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—B4GALT5—pharynx cancer	1.73e-05	0.00148	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—pharynx cancer	1.66e-05	0.00142	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ADH1B—pharynx cancer	1.65e-05	0.00141	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—pharynx cancer	1.64e-05	0.0014	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ADH1B—pharynx cancer	1.63e-05	0.00139	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CCND1—pharynx cancer	1.62e-05	0.00138	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—B4GALT5—pharynx cancer	1.57e-05	0.00134	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—B4GALT5—pharynx cancer	1.56e-05	0.00133	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—pharynx cancer	1.51e-05	0.00129	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CNDP2—pharynx cancer	1.49e-05	0.00127	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CCND1—pharynx cancer	1.48e-05	0.00127	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—pharynx cancer	1.39e-05	0.00118	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	1.36e-05	0.00116	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADH7—pharynx cancer	1.35e-05	0.00115	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—pharynx cancer	1.29e-05	0.0011	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD79A—pharynx cancer	1.19e-05	0.00102	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADH1B—pharynx cancer	1.18e-05	0.00101	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—pharynx cancer	1.16e-05	0.000993	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—pharynx cancer	1.13e-05	0.000965	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—B4GALT5—pharynx cancer	1.13e-05	0.000963	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDH1—pharynx cancer	1.13e-05	0.000961	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CNDP2—pharynx cancer	1.12e-05	0.000959	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDH1—pharynx cancer	1.1e-05	0.000937	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—pharynx cancer	1.07e-05	0.000912	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	1.04e-05	0.000889	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADH7—pharynx cancer	1.02e-05	0.000867	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—pharynx cancer	9.77e-06	0.000834	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADH1B—pharynx cancer	8.91e-06	0.00076	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—B4GALT5—pharynx cancer	8.51e-06	0.000727	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	8.17e-06	0.000698	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CNDP2—pharynx cancer	6.92e-06	0.000591	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	6.86e-06	0.000586	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—pharynx cancer	6.66e-06	0.000568	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—pharynx cancer	6.58e-06	0.000562	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADH7—pharynx cancer	6.26e-06	0.000534	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADH1B—pharynx cancer	5.49e-06	0.000468	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—B4GALT5—pharynx cancer	5.24e-06	0.000448	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—pharynx cancer	3.81e-06	0.000326	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—pharynx cancer	3.21e-06	0.000274	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—pharynx cancer	2.11e-06	0.00018	CbGpPWpGaD
